Reduction in MDH1 levels supports previous reports on the involvement of altered energy metabolism in late-onset AD [75, 76] while BDNF has been implicated in a protective role against Aβ peptides-induced neurotoxicity [77]. This evidence concerns the gene MDH1 and Alzheimer disease.